RE: Safe Option24 Sep 2025 14:46
"Avacta own - lock, stock and barrel - a patented chemical process called pre|CISION® that's successfully delivered, on at least ninety patients, a therapeutic warhead direct to cancer tumours. A world first. This invention is worth billions.
The first warhead chosen to prove pre|CISION® was a generic chemo called Doxorubicin."
If it is as cut and dried as this post implies, I just cannot understand why the big pharma companies are already fighting tooth and nail to get involved. That is, and has been for some time, my biggest concern.